Bluebird bio, Inc. and Celgene Corporation announced initial data from the ongoing Phase 1 clinical study of bb21217 (CRB-402), an...
Celltrion, Inc. announced that the EMA has accepted for review of the Extension Marketing Authorisation Application for ‘Remsima SC’, the...
QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, announced the expansion of its U.S.-based...
Shire plc the leading global biotechnology company focused on rare diseases, announced that the European Commission (EC) has granted Marketing...
GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in...
Merck, known as MSD outside the United States and Canada, announced that the EC has approved DELSTRIGO™ and PIFELTRO™ for...
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing...
Arsanis, Inc. and privately-held X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics...
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing...
MedPharm Ltd is pleased to announce that Eugene Ciolfi has joined as its President and Chief Executive Officer. In conjunction...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
